Characterization of Chronic Hand Eczema
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorDr. Robert Bissonnette
About this trial
Prospective longitudinal study to characterize Choronic Hand Eczema (CHE) subtypes and Atopic Dermatitis (AD) with noninvasive molecular and imaging techniques, and assess changes through time and its association with quality of life.
Eligibility criteria
Qualifiers
Male or female subjects aged 18 to 65 years, inclusive, at the time of consent.
Subject is willing to participate and is capable of giving informed consent. Note: Consent must be obtained prior to any study-related procedures.
Subject must be willing to comply with all study procedures and must be available for the duration of the study.
Subject has at least a 6-month history of CHE before Screening (information obtained from medical chart or subject's physician, or directly from the subject).
Disqualifiers
Subject has a history of skin disease or presence of skin condition that, in the opinion of the investigator, would interfere with the study assessments.
Subject has used systemic antibiotics within 2 weeks prior to Day 1.
Subject has used topical antibiotics within 1 week prior to Day 1.
Subject has used topical products containing urea or salicylic acid within 1 week prior to Day 1.
Trial design
Treatments tested in this trial
- Tape stripping
Treatment groups
270 Participants
are divided into 3 treatment groupsSponsors and collaborators
Dr. Robert Bissonnette
Lead sponsor
Innovaderm Research Inc.
Sponsor institution
Source ClinicalTrials.gov